July 10, 2026 · Form 4 insider transaction
Heidbreder Christian sold 18,586 shares of Indivior Pharmaceuticals, Inc. at $41.14 per share, a transaction worth $764.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.